First elected: 2023
Year of birth: 1977
Henrik Magnusson Hjorth is CEO of Novus Scientific. Henrik brings more than 15 years of experience from various roles within the medical device industry, including development, marketing and sales. He has focused most of his career on global market introductions of innovative medical technologies including products such as TIGR Matrix and OssDsign Cranial PSI. Henrik has a MSc in Molecular Biotechnology Engineering from Uppsala University.
Independence: Independent of the Company and the Executive Management and independent of major shareholders.
Other Board Assignments: Oncodia AB.
Holdings: 0 shares.